DaVita Inc. is projected to rise to $250.87 by 2027, a +29% move from its current price of $194.92. DVA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $191.85 | $195.01 | $198.22 | +0.05% |
| May 30 | $190.65 | $195.10 | $199.66 | +0.09% |
| May 31 | $189.75 | $195.19 | $200.79 | +0.14% |
| Jun 1 | $189.01 | $195.28 | $201.77 | +0.19% |
| Jun 2 | $188.37 | $195.38 | $202.64 | +0.23% |
| Jun 3 | $187.81 | $195.47 | $203.44 | +0.28% |
| Jun 4 | $187.29 | $195.56 | $204.19 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $187.29 | $195.56 | $204.19 | +0.33% |
| Week 2 | $184.58 | $196.20 | $208.56 | +0.66% |
| Week 3 | $182.66 | $196.84 | $212.13 | +0.99% |
| Week 4 | $181.15 | $197.49 | $215.31 | +1.32% |
| Week 5 | $179.90 | $198.14 | $218.23 | +1.65% |
| Week 6 | $178.83 | $198.79 | $220.97 | +1.98% |
| Week 7 | $177.90 | $199.44 | $223.58 | +2.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DaVita Inc. is a healthcare company that provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. It engages in the transplant software business. The company was incorporated in 1994 and is headquartered in Denver, Colorado.
DaVita Inc. (DVA) is a healthcare stock that trades at $198.52 per share and has a market capitalization of $12.74B. It ranks 779. The current price and market position set the stage for an overall price outlook reflected in the year-by-year forecast.
Forecasts show the average price by year rising from $198.52 in 2026 to $478.23 in 2030 and climbing to $3,092.96 by 2050, with higher implied value through 2040. The forecast also shows a long-run bullish trajectory, with the 2040 average of $1,331.78 and the 2050 average of $3,092.96.
A major floor 46.7% below — a decisive break under it would weaken the trend.
The nearest floor, 25.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 21.1% above — clearing it would confirm fresh momentum.
Key DVA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DVA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $196.91 | Sell | $196.27 | Sell |
| MA 10 | $196.91 | Sell | $194.66 | Buy |
| MA 20 | $186.36 | Buy | $186.97 | Buy |
| MA 50 | $164.96 | Buy | $170.28 | Buy |
| MA 100 | $148.46 | Buy | $156.29 | Buy |
| MA 200 | $137.27 | Buy | $146.44 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.46 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 35.24 | Neutral |
| Williams %R (14) | -70.60 | Info |
| MACD (12,26,9) | -0.72 | Sell |
| ROC (12) | -1.88 | Sell |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 29.40 | Neutral |
| TRIX (15) | 1.02 | Buy |
| Awesome (5,34) | 25.49 | Buy |
| Ultimate (7,14,28) | 43.19 | Neutral |
| Momentum (10) | -5.62 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 196.58 | Sell |
| ADX (14) | 35.00 | Buy |
| ATR (14) | 3.21 | Info |
The technical picture is bullish. RSI14 is 70, and the moving averages show a gradual positive tilt, with SMA50 at $163.13 and SMA200 at $136.61.
The 30-day price range runs from a low of $177.42 to a high of $222.13, with a nearby support at $144.57 and a resistance at $200.54. Annualized volatility is 30.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $103.87 | $194.92 | $259.90 | 0% | Neutral | |
| $204.94 | $250.87 | $321.44 | +29% | Bullish | |
| $227.92 | $284.08 | $373.51 | +46% | Bullish | |
| $273.47 | $346.03 | $464.42 | +78% | Bullish | |
| $352.35 | $451.78 | $617.07 | +132% | Bullish | |
| $386.77 | $501.89 | $696.20 | +157% | Bullish | |
| $421.91 | $553.62 | $778.76 | +184% | Bullish | |
| $467.76 | $620.20 | $883.60 | +218% | Bullish | |
| $497.80 | $666.56 | $960.89 | +242% | Bullish | |
| $558.53 | $754.92 | $1,100.28 | +287% | Bullish | |
| $873.31 | $1,230.92 | $1,879.50 | +532% | Bullish | |
| $1,866.63 | $2,821.25 | $4,616.32 | +13.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $103.87 | $194.92 | $228.00 | +0.00% |
| June 2026 | $170.44 | $198.83 | $236.45 | +2.01% |
| July 2026 | $173.37 | $203.41 | $244.18 | +2.31% |
| August 2026 | $171.74 | $202.41 | $244.74 | -0.49% |
| September 2026 | $172.65 | $204.23 | $248.42 | +0.90% |
| October 2026 | $178.17 | $211.48 | $258.62 | +3.55% |
| November 2026 | $179.27 | $213.43 | $262.23 | +0.92% |
| December 2026 | $176.38 | $210.59 | $259.90 | -1.33% |
Click any year to see its month-by-month DVA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DVA to range from $103.87 to $259.90 through 2026. The $194.92 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The DVA price prediction for 2027 points to an average of $250.87 (low $204.94, high $321.44) — a potential gain of +29% on today's $194.92. Buyers look set to stay in control over this stretch.
In 2028, DVA is projected to trade between $227.92 and $373.51, averaging $284.08 — a potential gain of +46% from today's $194.92. That is up +13% on the projected 2027 average. Momentum favours further upside here.
DaVita Inc.'s 2029 outlook centres on $346.03, within a $273.47 to $464.42 range. That is up +22% on the projected 2028 average. That marks a +78% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, DVA could reach as high as $617.07, with a base case around $451.78 and support toward $352.35 — roughly +132% from $194.92. Momentum favours further upside here.
Expect DVA to range from $386.77 to $696.20 through 2031. The $501.89 average target implies a +157% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The DVA price prediction for 2032 points to an average of $553.62 (low $421.91, high $778.76) — a potential gain of +184% on today's $194.92. Momentum favours further upside here.
In 2033, DVA is projected to trade between $467.76 and $883.60, averaging $620.20 — a potential gain of +218% from today's $194.92. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
DaVita Inc.'s 2034 outlook centres on $666.56, within a $497.80 to $960.89 range. That is up +7% on the projected 2033 average. That marks a +242% change versus current levels. Momentum favours further upside here.
By 2035, DVA could reach as high as $1,100.28, with a base case around $754.92 and support toward $558.53 — roughly +287% from $194.92. Buyers look set to stay in control over this stretch.
Expect DVA to range from $873.31 to $1,879.50 through 2040. The $1,230.92 average target implies a +532% move from current prices. That is up +63% on the projected 2035 average. Momentum favours further upside here.
The DVA price prediction for 2050 points to an average of $2,821.25 (low $1,866.63, high $4,616.32) — a potential gain of +13.5x on today's $194.92. Buyers look set to stay in control over this stretch.
Investing $1,000 in DVA today (≈ 5.13031 DVA) could be worth
$14,473.87
+$13,473.87 (+1347%) by 2050 · US Dollar
Based on the average projected DVA price of $2,821.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DVAwould be worth at today's price.
$1,000 invested in DVA on May 27, 2025 (≈ 7.148474 DVA) would be worth
$1,393.38
+$393.38 (+39.3%) today · 1.39× · US Dollar
Based on a DVA entry price of $139.89 vs. today's $194.92.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $196.87 | $990.1 | -1.0% |
| 1 month ago | $150.05 | $1,299.03 | +29.9% |
| 3 months ago | $152.54 | $1,277.83 | +27.8% |
| 6 months ago | $119.68 | $1,628.68 | +62.9% |
| 1 year ago | $139.89 | $1,393.38 | +39.3% |
| All time (5.0y) ago | $119.86 | $1,626.23 | +62.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DVA forecast.
Our base-case forecast reaches $390.00 around 2030.
Implied market cap at $390.00: $25.03B
The multi-year forecast points to a strong bullish trajectory. The 2030 forecast shows an average price of $478.23 with a 140.9 ROI, and the 2040 forecast shows an average price of $1,331.78 with a 570.9 ROI, while the 2050 forecast shows an average price of $3,092.96 with a 1458 ROI.
Beyond 2030, the model projects continued upside, including a 2027 average of $259.85 (ROI 30.9) and a 2029 average of $363.57 (ROI 83.1), with bullish sentiment persisting through 2050. These figures are estimates and not guarantees, and actual results will depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 avg $478.23; min $372.92; max $653.36; ROI 140.9; sentiment BULLISH.
Forecasts show bullish sentiment in 2027-2050, with rising avg prices and ROI: 2027 avg $259.85 (ROI 30.9), 2028 avg $295.45 (ROI 48.8), 2029 avg $363.57 (ROI 83.1), 2030 avg $478.23 (ROI 140.9).
2035 max $1,183.23; 2035 avg $811.71; therefore 2,000 is not indicated by the forecast.
Low $177.42; High $222.13.
Current price $198.52; Market cap $12.74B.
DaVita Inc. Community Discussion
0Share your DaVita Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.